Skip to content
← Retinoblastoma

HEALTH PROFESSIONAL · SOURCE READING

Treatment of Progressive or Recurrent Extraocular Retinoblastoma

Source: Retinoblastoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: April 3, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Context: Treatment of Progressive or Recurrent Retinoblastoma

Treatment options for progressive or recurrent extraocular retinoblastoma include the following:

Systemic chemotherapy and radiation therapy for orbital disease.

Systemic chemotherapy followed by myeloablative chemotherapy with stem cell rescue and radiation therapy for extraorbital disease.

Recurrence in the orbit after enucleation is treated with aggressive chemotherapy in addition to local radiation therapy because of the high risk of metastatic disease.[8][Level of evidence C1] After enucleation for recurrence, high-resolution magnetic resonance imaging with orbital coils can be helpful in distinguishing orbital recurrence from postsurgical enhancement.[9]

Source links and citations

If the recurrence or progression is extraocular, the chance of survival is poor.[10] However, the use of intensive systemic chemotherapy and consolidation with high-dose chemotherapy and autologous hematopoietic stem cell rescue may improve the chance of a cure, particularly for patients with extracranial recurrence. For patients with disease recurrence after those intensive approaches, clinical trials may be considered. For more information, see the Treatment of Extraocular Retinoblastoma section.

Source links and citations

Publication references

Read the original reference and check its publication notices.

Preserved source evidence · Not medical advice